Similar articles

• Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries.

  Goud R, Lufkin B, Duffy J, Whitaker B, Wong HL, Liao J, Lo AC, Parulekar S, Agger P, Anderson SA, Wernecke M, MaCurdy TE, Weintraub E, Kelman JA, Forshee RA. Goud R, et al. JAMA Intern Med. 2021 Dec 1;181(12):1623-1630. doi: 10.1001/jamainternmed.2021.6227. JAMA Intern Med. 2021. PMID: 34724025 Free PMC article.
• A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine.

  Yih WK, Kulldorff M, Dashevsky I, Maro JC. Yih WK, et al. Am J Epidemiol. 2022 Mar 24;191(5):957-964. doi: 10.1093/aje/kwac030. Am J Epidemiol. 2022. PMID: 35152283 Free PMC article.
• Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.

  Arya DP, Said MA, Izurieta HS, Perez-Vilar S, Zinderman C, Wernecke M, Alexander M, White T, Su IH, Lufkin B, MaCurdy T, Kelman J, Forshee R. Arya DP, et al. Vaccine. 2019 Oct 8;37(43):6543-6549. doi: 10.1016/j.vaccine.2019.08.045. Epub 2019 Sep 9. Vaccine. 2019. PMID: 31515146
• Guillain-Barré syndrome following hepatitis B vaccination.

  Khamaisi M, Shoenfeld Y, Orbach H. Khamaisi M, et al. Clin Exp Rheumatol. 2004 Nov-Dec;22(6):767-70. Clin Exp Rheumatol. 2004. PMID: 15638054 Review.
• Guillain - Barre' syndrome following recombinant hepatitis B vaccine and literature review.

  Sinsawaiwong S, Thampanitchawong P. Sinsawaiwong S, et al. J Med Assoc Thai. 2000 Sep;83(9):1124-6. J Med Assoc Thai. 2000. PMID: 11075984 Review.